Transposition of the great arteries
ORPHA:216675CategoryMultigenic/multifactorial, Not applicableInfancy, Neonatal
Эпидемиология18
| Тип оценки | Класс распространённости | Среднее (на 100к) | Регион | Квалификация |
|---|---|---|---|---|
| Prevalence at birth | 1-5 / 10 000 | 31.7 | Europe | Value and class |
| Prevalence at birth | 1-5 / 10 000 | 50 | United States | Value and class |
| Prevalence at birth | 1-5 / 10 000 | 23.3 | Belgium | Value and class |
| Prevalence at birth | 1-5 / 10 000 | 59.5 | Denmark | Value and class |
| Prevalence at birth | 1-5 / 10 000 | 33.4 | France | Value and class |
| Prevalence at birth | 1-5 / 10 000 | 47.5 | Germany | Value and class |
| Prevalence at birth | 1-5 / 10 000 | 28.8 | Hungary | Value and class |
| Prevalence at birth | 1-5 / 10 000 | 18.1 | Ireland | Value and class |
| Prevalence at birth | 1-5 / 10 000 | 22.6 | Italy | Value and class |
| Prevalence at birth | 1-5 / 10 000 | 40.9 | Netherlands | Value and class |
| Prevalence at birth | 1-5 / 10 000 | 31.1 | Norway | Value and class |
| Prevalence at birth | 1-5 / 10 000 | 14 | Poland | Value and class |
| Prevalence at birth | 1-9 / 100 000 | 4.7 | Portugal | Value and class |
| Prevalence at birth | 1-5 / 10 000 | 15.7 | Spain | Value and class |
| Prevalence at birth | 1-5 / 10 000 | 37.7 | Switzerland | Value and class |
| Prevalence at birth | 1-5 / 10 000 | 33.9 | United Kingdom | Value and class |
| Prevalence at birth | 1-5 / 10 000 | 22.3 | Ukraine | Value and class |
| Point prevalence | 1-5 / 10 000 | — | Europe | Class only |
Лекарства и терапия
Источник: Open Targets Platform (в реальном времени)
Клинические исследования
Источник: ClinicalTrials.gov (в реальном времени)